A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa
Angela Huttner(University Hospital of Geneva), Claire‐Anne Siegrist(University of Geneva), Christophe Combescure, Jessica S. Brosnahan(Centre de Recherche Médicales de Lambaréné), Edwin Quinten(Leiden University Medical Center), Mariëlle C. Haks(Leiden University Medical Center), Julie-Anne Dayer(Flinders University), Peter G. Kremsner(Centre de Recherche Médicales de Lambaréné), Ali M. Harandi(University of British Columbia), Laurent Kaiser(University Hospital of Geneva), Christine Modoux(University Hospital of Geneva), Stéphane Grillet(World Health Organization), Sélidji Todagbé Agnandji(Centre de Recherche Médicales de Lambaréné), Pascale Roux‐Lombard(Universitätsklinikum Tübingen), Tom H. M. Ottenhoff(Office of Infectious Diseases), T P Monath(Altimmune (United Kingdom)), Donata Medaglini(University of Siena)
Cited by 64
Related Papers
ICTV Virus Taxonomy Profile: Flaviviridae
|Journal of General Virology|2017|851
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans
|Human Immunology|2004|413